About 3DHEALS Company Directory:

3DHEALS updates this collection of public and private companies, government and non-government institutions, and any relevant research organizations in healthcare 3D printing, bioprinting, AR/VR, 3D technologies, on a weekly basis. Access to this directory is free to 3DHEALS Premium and Enterprise members. 

THIS CONTENT IS FOR PREMIUM AND ENTERPRISE MEMBERS ONLY.

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

blank

Cutiss

Personalized & bioengineered human skin tissue therapy for patients with severe burns and skin injuries

Headquarters Grabenstrasse 11 Schlieren 8952 Switzerland
  • blank
  • blank
  • blank
Categories: Bioprinting /Biofabrication
Website: cutiss.swiss/
Phone: +41 44 244 36 60
Links:

Details

Our mission: to give patients back more of their own skin to make them well again.

CUTISS is a Swiss clinical-stage life sciences company focussed on regenerative medicine, skin tissue engineering, and skin pigmentation.

We are developing the first personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries.

Our lead product denovoSkin promises to take skin surgery to the next level and revolutionize current treatments. It is a bio-engineered and personalized dermo-epidermal human skin graft, currently in Phase 2 clinical trials in Switzerland and the European Union. It has Orphan Drug Designation for the treatment of burns from Swissmedic, EMA, and FDA.

CUTISS is also developing the world’s first machine that can automate the entire production process of the personalised skin graft.

Our company’s knowledge in skin bio-engineering and biology offers other growth opportunities in regenerative medicine, and also beyond the medical domain.

Established in 2017, CUTISS is a spin-off from University of Zurich (UZH) / University Children’s Hospital. We successfully exited the Wyss Zurich accelerator in 2022.

Headquartered at the Bio-Technopark in Zurich, CUTISS won the Top 100 Swiss Startup Award 2020, and has raised over CHF 55 million from private investors, family offices and public bodies.

CBD for pain is gaining traction as a complementary option for everyday discomfort, offering potential anti-inflammatory benefits and calmer sensations without strong sedatives. Results vary, so start with a low dose, choose reputable full- or broad-spectrum products, and monitor changes. Always consult a healthcare professional if you have underlying conditions or take other medications. cbdclub.top